Page 5 - Bharat Biotech
WHO chief, Mandaviya talk Covaxin, resuming Covishield supply to COVAX
WHO chief Tedros Adhanom Ghebreyesus discussed the issue of the emergency use listing of Bharat Biotech's COVID-19 vaccine Covaxin and resumption of supplies of the Serum Institute of India-manufactured AstraZeneca vaccine to the COVAX facility among other topics during a telephonic conversation with Health Minister Mansukh Mandaviya. Had a call with @mansukhmandviya, India's Health Minister, to discuss #India's ongoing #COVID19 vaccination programme; the need for a global pandemic agreement; digital health; & traditional medicine. We welcome India's support to strengthen WHO, incl. via flexible, sustainable financing, Ghebreyesus tweeted on Tuesday. The WHO Director-General said that he also discussed with Mandaviya vaccine equity issues: the resumption of SII/AstraZeneca vaccine supplies to #COVAX; the Covaxin Emergency Use Listing process; and technology and license sharing through C-TAP. COVID-19 Technology Access Pool (C-TAP) was launched in May last year for facilitating ...
 "WHO chief, Mandaviya talk Covaxin, resuming Covishield supply to COVAX")
Top headlines: Govt plans IDBI sale; chief economist Gopinath to leave IMF
India's drug regulator is examining recommendation by experts for approving Bharat Biotech's Covaxin for children. More in top headlines this morning.
 "Top headlines: Govt plans IDBI sale; chief economist Gopinath to leave IMF")
Bharat Biotech's Covaxin roll-out for children likely in phases
Vaccine performance, availability being evaluated
 "Bharat Biotech's Covaxin roll-out for children likely in phases")
Long wait: Vaccine makers queue up for WHO approval, shows data
Industry insiders say typically a WHO EUL takes between two months and a year
 "Long wait: Vaccine makers queue up for WHO approval, shows data")
WHO expecting more info from Bharat Biotech for Covaxin approval
Covaxin is one of the three approved vaccines that have been used in India for the country's vaccination drive for adults.
 "WHO expecting more info from Bharat Biotech for Covaxin approval")
Top headlines: NCLT setback for Amazon; WHO seeks more info for Covaxin
Business Standard brings you the top stories from today
 "Top headlines: NCLT setback for Amazon; WHO seeks more info for Covaxin")
WHO's technical group to meet on Oct 26 to consider EUL of Covaxin
The WHO experts are currently reviewing this information and if it addresses all questions raised, the WHO assessment will be finalised next week
 "WHO's technical group to meet on Oct 26 to consider EUL of Covaxin")
Bharat Biotech's Covaxin gets expert panel's nod for children above 2 years
First Covid-19 vaccine in the world for children this young
 "Bharat Biotech's Covaxin gets expert panel's nod for children above 2 years")
Awaiting regulatory nod to launch Covaxin for children: Bharat Biotech
The expert panel of India's Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children in the 2 to 18 years age group with certain conditions.
 "Awaiting regulatory nod to launch Covaxin for children: Bharat Biotech")
Bharat Biotech submits clinical trial data for paediatric vaccine to DCGI
The vaccine maker added that Covaxin is the first Covid-19 vaccine to be tested in the 2-6-year age group
WHO technical advisory group to take call on Covaxin EUL next week
Vaccine maker presented data before SAGE working group on Tuesday
Scientists' body expresses concern over WHO not granting EUL for Covaxin
A national network of scientists, AIPSN, has expressed concern over the World Health Organisation not granting emergency use listing for ICMR-Bharat Biotech's Covaxin.
Decision on Bharat Biotech's Covaxin EUL in October, says WHO
A decision on Bharat Biotech's submission seeking emergency use listing (EUL) for its Covaxin COVID-19 vaccine will be made in October, the World Health Organisation has said
Diligently working with WHO to obtain EUL for Covaxin: Bharat Biotech
The vaccine maker said it will make on announcement to indicate the availability of regulatory approval at an appropriate time
 "Diligently working with WHO to obtain EUL for Covaxin: Bharat Biotech")
Top headlines: PM Modi reaches New York, FinMin withdraws spending curbs
Business Standard brings you the top headlines on Saturday
Booster dose: Bharat Biotech's nasal vaccine may be used with Covaxin
The idea is to see which combination induces better and long-lasting immune response
Bharat Biotech injects pace into Covid-19 vaccine Covaxin supply
Constraints on the availability of India's first indigenous Covid-19 vaccine could end soon
 "Bharat Biotech injects pace into Covid-19 vaccine Covaxin supply")
Bharat Biotech likely to start manufacturing Covaxin at Pune plant soon
Animal vaccine maker Hester Biosciences, on the other hand, is setting up a greenfield BSL-3 facility in Gujarat to make Covaxin
Paediatric Covaxin: Bharat Biotech completes phase 2/3 trials of vaccine
Bharat Biotech has completed Phase 2/3 trials of Covid-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the DCGI
WHO Experts' Group to take a call on EUL for Covaxin on October 6
The Strategic Advisory Group of Experts on Immunization of the WHO would be meeting in October to make its recommendations on Bharat Biotech's COVID-19 vaccine Covaxin on Emergency Use Listing
